Trials / Terminated
TerminatedNCT06282614
Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
MOVHYDA (MUCO245) - Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Biocodex · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this post-Market Clinical Follow-up (PMCF) study is to confirm the efficacy and safety of MUCOGYNE® Ovule in the maintainance of natural moisture of the vulvovaginal mucosa and in the compensation for any natural secretions deficiencies, when used in accordance with its approved labeling, in the context of vulvovaginal dryness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mucogyne Ovule | At inclusion visit (V0), the Investigator will ask the subject to use MUCOGYNE® Ovule 2 times a week until symptoms improve during 5 weeks (D35± 3) preferably at bedtime |
Timeline
- Start date
- 2024-04-11
- Primary completion
- 2025-02-14
- Completion
- 2025-02-14
- First posted
- 2024-02-28
- Last updated
- 2025-04-13
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06282614. Inclusion in this directory is not an endorsement.